Topics

Medtronic gets FDA nod for Evolut PRO+ TAVR system

07:16 EDT 24 Sep 2019 | Compelo Medical Devices

Medtronic has secured approval from the US Food and Drug Administration (FDA) for its next-generation Evolut PRO+ TAVR system to treat symptomatic severe aortic stenosis patients. The company

Related Biotechnology, Pharmaceutical and Healthcare News

The post Medtronic gets FDA nod for Evolut PRO+ TAVR system appeared first on NS Medical Devices.

Original Article: Medtronic gets FDA nod for Evolut PRO+ TAVR system

NEXT ARTICLE

More From BioPortfolio on "Medtronic gets FDA nod for Evolut PRO+ TAVR system"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored ND2A Group with offices at 677 Craig Rd, Suite 216, Creve Coeur, Missouri 63141 USA. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact ND2A Group.

All rights reserved. All other trademarks recognized. Copyright © 2019 ND2A Group. Site developed by Alacrify Ltd

.